NanoViricides, Inc. Anti-Herpes Drug Candidate Reduces Viral Load by 99.99%
Aug 10, 2009 – NanoViricides, Inc. , announced today that the herpes simplex viral load was reduced by 99.99% or 10,000 fold in in-vitro studies by nanoviricides drug candidates.
If you enjoyed this post, make sure you subscribe to my RSS feed!
